Mechanistic Analysis of Papillimavirus E2 Functions
乳头状病毒E2功能的机制分析
基本信息
- 批准号:7772357
- 负责人:
- 金额:$ 26.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsApplications GrantsBenignBindingBinding SitesBiologicalBovine PapillomavirusBovine Papillomavirus-1BromodomainCell CommunicationCell NucleusCell ProliferationCell divisionCellsChromosomesComplexCytoplasmDNA biosynthesisDNA replication originElementsEnsureFamilyGenetic ScreeningGenetic TranscriptionGenomeHPV analysisHistone H4HumanHuman PapillomavirusHuman papillomavirus 16InfectionLaboratoriesLeadLeftLesionLife Cycle StagesLinkLocationMaintenanceMalignant neoplasm of cervix uteriMitosisMitotic ChromosomeMitotic spindleModelingMusNuclearNuclear EnvelopePapillomavirusPapillomavirus InfectionsPapillomavirus Protein E2PathogenesisPlasmidsPlayProliferatingProtein BindingProteinsProteomicsPublishingReportingResearch Project GrantsRoleTestingTimeTrans-ActivatorsTranscription CoactivatorVertebratesViralViral GenomeViral ProteinsVirusWorkYangbasecell transformationchemical geneticsdaughter cellgenetic regulatory proteinin vivoinhibitor/antagonistinsightmembernovelnovel therapeuticsreceptorsmall moleculetelophasetooltumorviral DNA
项目摘要
The papillomaviruses (PVs) are a group of small DMAviruses that induce benign lesions in variety of higher
vertebrates, including humans. Certain papillomaviruses, including the human papillomaviruses (HPVs) such
as HPV16 and 18, are also associated with the pathogenesis of cervical cancer and other human tumors.
Papillomaviruses establish persistent infections in which the viral genomes are maintained as autonomous
replicating plasmids at a low copy number in the nuclei of proliferating host cells. In bovine papillomavirus
(BPV1) transformed mouse cells, the viral genomes also replicate as multicopy nuclear plasmids that can
persist over long periods of time to maintain the transformation status of the cells. To ensure persistence in
both infected and transformed cells, the replicated viral genomes must be partitioned and maintained in the
nuclei of daughter cells following mitosis. Without a mechanism to ensure the localization of the viral
genome within the nuclear envelope following nuclear reassembly, the viral genome could be left behind in
the cytoplasm and lost either through degradation or dilution after cell division. The papillomavirus E2
protein, which is an important regulatory protein that plays critical roles in viral transcriptional and viral DNA
replication, is also required for viral genome maintenance in dividing cells. E2, as well as the PV genomes,
are closely associated with mitotic chromosomes in dividing cells. Utilizing a proteomic approach to
systematically characterize cellular proteins that associate with E2 in vivo, we recently identified Brd4
(bromodomain-containing protein 4) as an E2 interacting protein and showed that it functions as the mitotic
chromosome receptor for BPV1 E2. The focus of this research grant is to extend these studies on the PV E2
proteins and to examine the functional significance of the interaction of E2 with Brd4 to other aspects of the
viral life cycle. Disruption of the binding of E2 to Brd4 can block the transformation of cells by BPV1 and the
association of E2 and the viral DNA with mitotic chromosomes. Chemical genetic screens will be conducted
to identify small molecule inhibitors of E2/Brd4 binding as potential lead molecules for novel therapeutic
antiviral compounds.
乳头瘤病毒(PV)是一组小的DMA病毒,可引起多种组织的良性病变。
脊椎动物,包括人类。某些乳头状瘤病毒,包括人乳头瘤病毒(HPV),如
与HPV16和HPV18一样,也与宫颈癌和其他人类肿瘤的发病机制有关。
乳头瘤病毒建立持续的感染,在这种感染中,病毒基因组保持自主
在增殖的宿主细胞的细胞核中以低拷贝数复制质粒。在牛乳头瘤病毒中
(BPV1)转化的小鼠细胞,病毒基因组也以多拷贝核质粒的形式复制,可以
持续较长时间,保持细胞的转化状态。要确保持久化
无论是被感染的细胞还是转化的细胞,复制的病毒基因组都必须被分割并在
有丝分裂后的子细胞的核。没有机制来确保病毒的本地化
核膜内的基因组在核重组后,病毒基因组可能会留在
细胞分裂后由于降解或稀释而丢失的细胞质。乳头瘤病毒E2
蛋白质,这是一种重要的调节蛋白,在病毒转录和病毒DNA中发挥关键作用
复制,也是在分裂细胞中维持病毒基因组所必需的。E2,以及PV基因组,
在细胞分裂过程中与有丝分裂染色体密切相关。利用蛋白质组学方法
在体内系统地表征与E2相关的细胞蛋白,我们最近发现了Brd4
(含溴结构域的蛋白4)作为一种E2相互作用蛋白,并表明它具有有丝分裂的功能
BPV1E2的染色体受体。这项研究拨款的重点是延长这些关于光伏E2的研究
并研究了E2与Brd4相互作用对蛋白质其他方面的功能意义。
病毒的生命周期。破坏E2与Brd4的结合可以阻断BPV1和BPV1对细胞的转化
E_2和病毒DNA与有丝分裂染色体的关系将进行化学基因筛查
寻找E2/Brd4结合的小分子抑制剂作为新型治疗药物的潜在先导分子
抗病毒化合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter M Howley其他文献
Peter M Howley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter M Howley', 18)}}的其他基金
Molecular Biology of Oncogenic Papillomaviruses
致癌乳头瘤病毒的分子生物学
- 批准号:
10322439 - 财政年份:2016
- 资助金额:
$ 26.29万 - 项目类别:
Molecular Biology of Oncogenic Papillomaviruses
致癌乳头瘤病毒的分子生物学
- 批准号:
10057232 - 财政年份:2016
- 资助金额:
$ 26.29万 - 项目类别:
Molecular Biology of Oncogenic Papillomaviruses
致癌乳头瘤病毒的分子生物学
- 批准号:
8952443 - 财政年份:2016
- 资助金额:
$ 26.29万 - 项目类别:
Small Molecule Screen Targeting p53 proteolysis in HPV positive cancers
针对 HPV 阳性癌症中 p53 蛋白水解的小分子筛选
- 批准号:
8641680 - 财政年份:2013
- 资助金额:
$ 26.29万 - 项目类别:
Small Molecule Screen Targeting p53 proteolysis in HPV positive cancers
针对 HPV 阳性癌症中 p53 蛋白水解的小分子筛选
- 批准号:
8489916 - 财政年份:2013
- 资助金额:
$ 26.29万 - 项目类别:
Papillomavirus E2 Growth Suppression Mechanisms
乳头瘤病毒 E2 生长抑制机制
- 批准号:
8233032 - 财政年份:2011
- 资助金额:
$ 26.29万 - 项目类别:
Papillomavirus E2 Growth Suppression Mechanisms
乳头瘤病毒 E2 生长抑制机制
- 批准号:
7647591 - 财政年份:2009
- 资助金额:
$ 26.29万 - 项目类别:
Papillomavirus E2 Functions: Cellular Regulation and Effectors
乳头瘤病毒 E2 功能:细胞调节和效应器
- 批准号:
8435813 - 财政年份:2006
- 资助金额:
$ 26.29万 - 项目类别:
Mechanistic Analysis of Papillimavirus E2 Functions
乳头状病毒E2功能的机制分析
- 批准号:
7105179 - 财政年份:2006
- 资助金额:
$ 26.29万 - 项目类别:
Mechanistic Analysis of Papillimavirus E2 Functions
乳头状病毒E2功能的机制分析
- 批准号:
7909331 - 财政年份:2006
- 资助金额:
$ 26.29万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 26.29万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 26.29万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 26.29万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 26.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 26.29万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 26.29万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 26.29万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 26.29万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 26.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 26.29万 - 项目类别: